Alambic Investment Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-17,796
Closed -$80K 297
2019
Q4
$80K Sell
17,796
-14,704
-45% -$46.5K 0.07% 254
2019
Q3
$135K Sell
32,500
-3,400
-9% -$12.3K 0.1% 244
2019
Q2
$136K Sell
35,900
-6,200
-15% -$25.4K 0.08% 254
2019
Q1
$176K Sell
42,100
-5,500
-12% -$19.2K 0.07% 295
2018
Q4
$119K Buy
47,600
+23,309
+96% +$137K 0.05% 272
2018
Q3
$177K Sell
24,291
-56,514
-70% -$247K 0.14% 223
2018
Q2
$299K Sell
80,805
-30,277
-27% -$140K 0.08% 272
2018
Q1
$428K Buy
111,082
+15,938
+17% +$67K 0.06% 338
2017
Q4
$343K Sell
95,144
-8,795
-8% -$33.2K 0.04% 361
2017
Q3
$411K Buy
103,939
+89,990
+645% +$413K 0.04% 374
2017
Q2
$71K Buy
+13,949
New +$78.3K 0.01% 543

Other funds holding AGTC

Alambic Investment Management's AGTC Position: Q1 2020 in Review

Alambic Investment Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2020, closing a stake of 17,796 shares — an estimated $80K sold.

Alambic Investment Management first reported a position in AGTC in Q2 2017 and held it in 11 quarters. The position peaked at $428K in Q1 2018. 59 funds tracked by Wall St. Rank hold AGTC as of Q1 2020.

  • Alambic Investment Management reported no remaining Applied Genetic Technologies Corporation position as of Q1 2020 after selling out during the quarter.
  • Alambic Investment Management sold 17,796 Applied Genetic Technologies Corporation shares in Q1 2020, an estimated $80K.
  • Alambic Investment Management first reported a position in Applied Genetic Technologies Corporation in Q2 2017 and held it in 11 quarters.
  • Alambic Investment Management's Applied Genetic Technologies Corporation position peaked at $428K in Q1 2018.
  • 59 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2020.

Based on Alambic Investment Management's 13F filing for Q1 2020, filed 11 May 2020.